Learning Objectives: 

1.  Understanding the challenges of clinical care and research for rare CNS tumors.

2.  Learn strategies to advance the field and the mission and activities of the NCI-CONNECT program.

3.  Learn about opportunities for personalized therapy for tumors with MYC and MYCN amplifications.

Session date: 
03/27/2024 - 8:00am to 9:00am CDT
Location: 
D1.602
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA
  • 1.00 Attendance
Please login or create an account to take this course.
Faculty List: 
Course Director(s)

Peter Sguigna, MD

has a financial relationship (Professional Services) with Clene NanoMedicine;.
has a financial relationship (Professional Services) with Genentech;.
has a financial relationship (Independent contractor) with Genentech;.
has a financial relationship (Independent contractor) with Bristol Myers Squibb;.
has a financial relationship (Intellectual Property Other) with VIC Tech;.
has a financial relationship (Independent contractor) with Medscape;.
has a financial relationship (Independent contractor) with Spherix Global Insights;.
has a financial relationship (Independent contractor) with Guidepoint;.
has a financial relationship (Independent contractor) with Horizon Therapeutics;.
has a financial relationship (Independent contractor) with EMD Serono;.
Peer reviewer(s)

Kan Ding, MD

has no relevant financial relationships to disclose at this time.
Planner(s)

Keysha Hale, N/A

has no relevant financial relationships to disclose at this time.

Zachary Roesch

has no relevant financial relationships to disclose at this time.
Speaker(s)

Marta Penas-Prado, MD MSc

has no relevant financial relationships to disclose at this time.